We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
15
0 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Completed
9
60.0%
Terminated
1
6.7%
Unknown
3
20.0%
Withdrawn
2
13.3%
No approval data available
- Cancer diagnosis rates in people under age 50 rose roughly 22% from 2000 to 2023, driving rapid growth in the oncofertility field. - Fertility preservation consultations for cancer patients surged, with Boston IVF's New England clinics rising from 19 patients in 2015 to 183 in 2025. - A Dana-Farber trial found early, hormone-sensitive breast cancer survivors could pause hormone therapy for up to two years to conceive without raising recurrence risk. - Despite progress, patients still face barriers including time pressure, limited awareness, and high out-of-pocket costs for fertility preservation.
